Jilin Jian Yisheng Pharmaceutical Co., Ltd. Share Price
Equities
002566
CNE1000011C3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.86 CNY | -3.65% | -3.79% | -23.01% |
Sales 2022 | 830M 115M 9.15B | Sales 2023 | 854M 118M 9.41B | Capitalization | 2.95B 407M 32.5B |
---|---|---|---|---|---|
Net income 2022 | 83M 11.46M 915M | Net income 2023 | 94M 12.97M 1.04B | EV / Sales 2022 | 3.28 x |
Net Debt 2022 | 40.44M 5.58M 446M | Net cash position 2023 | 114M 15.72M 1.26B | EV / Sales 2023 | 3.32 x |
P/E ratio 2022 |
32.3
x | P/E ratio 2023 |
31.1
x | Employees | 1,678 |
Yield 2022 |
0.62% | Yield 2023 |
1.68% | Free-Float | 52.64% |
1 day | -3.65% | ||
1 week | -3.79% | ||
Current month | -4.85% | ||
1 month | -3.38% | ||
3 months | -14.78% | ||
6 months | -18.24% | ||
Current year | -23.01% |
Managers | Title | Age | Since |
---|---|---|---|
Xiao Min Xie
CEO | Chief Executive Officer | 66 | 31/12/08 |
Jian Tao Bi
DFI | Director of Finance/CFO | 54 | 31/07/11 |
Tie Jun Li
PSD | President | 64 | 31/12/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Li
BRD | Director/Board Member | 62 | 07/05/19 |
Yi Sheng Zhang
CHM | Chairman | 68 | 31/12/99 |
Jian Tao Bi
DFI | Director of Finance/CFO | 54 | 31/07/11 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 6.86 | -3.65% | 12,354,530 |
25/04/24 | 7.12 | +2.45% | 7,281,600 |
24/04/24 | 6.95 | +1.02% | 6,787,400 |
23/04/24 | 6.88 | +2.08% | 10,164,100 |
22/04/24 | 6.74 | -5.47% | 19,097,800 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-23.01% | 313M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 002566 Stock